Phase I Clinical Study to Evaluate SYS6055 Injection in Participants With Relapsed/Refractory B-Cell Malignancies
Clinical trial NCT07493174 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07493174
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-15
- Primary completion
- 2028-04-15
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.